New Delhi : The Delhi High Court has granted an ex-parte ad-interim injunction restraining Carens Pharmaceuticals from manufacturing or selling veterinary or pharmaceutical preparations under the mark CALDIMUST, holding that the mark and label were deceptively similar to Mankind Pharma's registered trademark CALCIMUST.

The order was passed by Justice Tejas Karia in a commercial suit filed by Mankind Pharma Limited seeking protection of its registered trademarks, copyright, and other related rights.

Mankind Pharma, incorporated in 1991, is one of India’s leading pharmaceutical manufacturers and marketers. The company adopted the trademark ‘CALCIMUST’ in 2009 for its veterinary range and subsequently registered it under the Trade Marks Act, along with ‘MANKIND’s CALCIMUST’.

In the year 2

See Full Page